Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Interpace Biosciences (IDXG) News Today

Interpace Biosciences logo
PDI: Beware The Massive NAV Premium
Interpace Biosciences Inc.
Interpace Biosciences Reports Impressive Q3 2024 Growth
PDI: The Big ROC Bath, 13.5% 'Yield'
Healthcare Stocks Pre-Market Movers
PF42.SG,0P00019E71,0 (PF42.SG)
PDI: 14% Yield, But Risks Are Rising (Rating Downgrade)
PDI: Lag Likely To Continue
PDI: Pain Could Be On The Horizon
PDI And PTY: Unwelcome ROC, Buyer Beware
PTY And PDI: Abysmal Setups
PDI Vs. PDO: Which High-Yielder Is Better?
PDI: More Patience Required
PDI: Utility Maximizing Income Fund
The PDI And PTY Dilemma
Interpace Biosciences, Inc. (IDXG)
PDI: Likely More Short-Term Pain Ahead
Colorado-based biotech acquires Morrisville lab
Get Interpace Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter.

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

IDXG Media Mentions By Week

IDXG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IDXG
News Sentiment

0.00

0.47

Average
Medical
News Sentiment

IDXG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IDXG Articles
This Week

0

0

IDXG Articles
Average Week

Get Interpace Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IDXG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners